|
| |
| | | 70214 | | 21.05.2026 | | Eli Lilly (Suisse) SA | | | | | | | 20.05.2031 | | | | | | 70000. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Retsevmo 40 mg | comprimés pelliculés | Coated tablets (Selpercatinibum 40 mg) | L01EX22 | CI | | 02 | Retsevmo 80 mg | comprimés pelliculés | Coated tablets (Selpercatinibum 80 mg) | L01EX22 | CI |
|
|
|
